Well form would suggest that IMU will pull a cap raise at any moment. I'm not following closely because I'm out, but my reading is they are trying to capital bridge from B-cell to the Oncalytic virus which is barely off the ground. PTX is doing the same with Omni. The difference is that PTX is worth $40mil and Omni looks a lot more promising. AIMO
Ann: Imugene Receives PD1-VAXX Ethics Trial Approval in USA, page-137
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $174.5K | 3.590M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 7948479 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 2348875 | 24 |
View Market Depth
| Last trade - 13.49pm 04/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |